Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Advertisement
Set Alert for Articles By Tom Gallen

Latest From Tom Gallen

GSK And Perrigo Issue Recalls In Sweden After Metal Staple Found In Rectal OTC

A metal staple found in GSK's Alvedon children's pain relief product in Sweden has prompted a recall which also encompasses Perrigo's Panodil brand.
Product Recalls OTC Drugs

Ranitidine Recalls Begin As European Regulators Take Action

OTC ranitidine products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.

Product Recalls Drug Safety

Ranitidine Recalls Begin In Europe As Regulators Take Action

OTC products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.
Product Recalls Drug Safety

Bayer R&D Center To Uncover Chinese Insights

A new dedicated R&D facility for Bayer Consumer Health in China will enable the firm to “quickly take the pulse of the market” and transform demand into innovative products.

Innovation China

Omega-3 Supplements For Depression? Major Study Says Yes

Omega-3, folate and amino acid supplements are an effective additional treatment for number of mental health conditions including depression and bipolar disorder, show the results of a major study.

Europe Asia Pacific

High-Dose Statins Could Go OTC In The UK

The NHS wants to make high-dose statins available OTC in the UK and will work with regulators and industry to make it happen. Such a switch could open up a whole new consumer health category in the country, moving the industry into treatments for chronic conditions. 

OTC Drugs Prescription To Otc Switch
See All
Advertisement
UsernamePublicRestriction

Register